Matthew Henn
Chief Tech/Sci/R&D Officer at SERES THERAPEUTICS, INC.
Net worth: 47 133 $ as of 2024-04-29
Matthew Henn active positions
Companies | Position | Start | End |
---|---|---|---|
SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-02-06 | - |
Corporate Officer/Principal | 2012-05-31 | 2019-02-06 |
Career history of Matthew Henn
Former positions of Matthew Henn
Companies | Position | Start | End |
---|---|---|---|
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2005-02-28 | 2012-05-31 |
Viral Genomics, Inc. | Director/Board Member | - | - |
Training of Matthew Henn
University of California, Berkeley | Doctorate Degree |
University of New Hampshire | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SERES THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Viral Genomics, Inc. | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Matthew Henn
- Experience